NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

National guideline on post-menopausal bleeding completed

By Catherine Reilly - 19th Jul 2022

clinical guidelines

A national guideline for the assessment and management of post-menopausal bleeding (PMB) has been developed and will be disseminated to all relevant sites in the coming weeks. 

A HSE spokesperson told the Medical Independent: “Similar to the interim guidance, the new guidelines will recommend that women referred with PMB be seen within 28 days of referral [and] that women referred with PMB receive a diagnosis and relevant test results within 28 days of review in clinic. Finally, the guideline recommends that women referred with PMB receive a histological confirmation of diagnosis within 12 weeks of referral received. These timelines are deemed clinically appropriate.” 

The HSE National Women and Infant Health Programme (NWIHP) will work with the HSE Business Intelligence Unit to devise key performance indicators (KPIs) to monitor the recommendations of the national PMB guidelines. It is envisaged that these KPIs will be captured and collated nationally on a quarterly basis. 

In addition, a GP gynaecology e-referral form is in the final stages of drafting. 

“The form is intended to complement the existing Healthlink general e-referral form and will be premised on clearly highlighted clinical ‘red-flags’ that warrant an urgent outpatient appointment. The proposed e-referral will facilitate the clinical prioritisation process in the acute setting.” 

The 2020 Price report into cases of missed/delayed diagnoses of endometrial cancer at Letterkenny University Hospital had referenced “an absence of national standards for women who present with post-menopausal bleeding, and an absence of clear timelines for assessment, investigation and treatment on presentation”. The HSE subsequently issued interim guidelines. 

A HSE report into the national endometrial cancer diagnosis timeline, dated July 2021, found that the average time from referral to date of histological diagnosis was 14 weeks. The report, which examined cases of endometrial cancer diagnosed in 2019, stated there was “scope to shorten the time to diagnosis at a system level” by optimising the investigation and management of women with PMB.

Its recommendations included continued development of the ambulatory gynaecology model of care, national clinical guidance on PMB with KPIs, and gynaecology referral forms.

Leave a Reply

Latest Issue
medical independent 21st November
The Medical Independent 21st November 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read